Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Michael R. McAleveyEVP & Chief Legal & Admin Off | HCA HealthcareHCA | Open-market sale | 02/18 | 02/18 | 1,694 sh | $533.37 | $903,528.78 | −16.1% |
Christopher F. WyattSVP & Controller | HCA HealthcareHCA | Open-market sale | 02/11 | 02/12 | 4,000 sh | $505.00 | $2,020,000 | −8.3% |
HCA HealthcareHCA | Open-market sale | 02/11 | 02/12 | 8,020 sh2 trades | $514.58avg. | $4,126,931.6 | −40.1% | |
HCA HealthcareHCA | Open-market sale | 02/03 | 02/05 | 42,877 sh7 trades | $501.04avg. | $21,483,289.19 | −57.1% | |
Michael S. CuffeEVP and Chief Clinical Officer | HCA HealthcareHCA | Open-market sale | 02/03 | 02/05 | 1,500 sh | $498.09 | $747,135 | −4.8% |
Michael R. McAleveyEVP & Chief Legal & Admin Off | HCA HealthcareHCA | Open-market sale | 25/11/05 | 25/11/05 | 3,892 sh | $473.79 | $1,843,990.68 | −52.7% |
Michael S. CuffeEVP and Chief Clinical Officer | HCA HealthcareHCA | Open-market sale10b5-1 plan | 25/09/08 | 25/09/08 | 3,836 sh | $418.84 | $1,606,670.24 | −10.9% |
Jon M. FosterEVP and COO | HCA HealthcareHCA | Open-market sale | 25/05/13 | 25/05/15 | 15,698 sh | $369.32 | $5,797,585.36 | −55.4% |
10% Owner | HCA HealthcareHCA | Open-market sale | 12/01/10–12/04/03 | 25/03/28 | 3,178 sh17 trades | $25.11avg. | $79,810.89 | −100.0% |
HCA HealthcareHCA | Open-market sale | 12/01/10–12/04/03 | 25/03/28 | 3,178 sh17 trades | $25.11avg. | $79,810.89 | −100.0% | |
HCA HealthcareHCA | Open-market sale | 12/01/10–12/04/03 | 25/03/28 | 3,178 sh17 trades | $25.11avg. | $79,810.89 | −100.0% | |
10% Owner | HCA HealthcareHCA | Open-market buy | 11/07/26–12/03/19 | 25/03/28 | 3,436 sh13 trades | $25.67avg. | $88,208.12 | No record |
HCA HealthcareHCA | Open-market buy | 11/07/26–12/03/19 | 25/03/28 | 3,436 sh13 trades | $25.67avg. | $88,208.12 | No record | |
HCA HealthcareHCA | Open-market buy | 11/07/26–12/03/19 | 25/03/28 | 3,436 sh13 trades | $25.67avg. | $88,208.12 | No record | |
HCA HealthcareHCA | Open-market sale | 25/02/14 | 25/02/18 | 9,533 sh2 trades | $322.59avg. | $3,075,281.98 | −38.2% | |
Whalen Kathleen M.SVP & Chief Ethics Officer | HCA HealthcareHCA | Open-market sale | 24/11/14 | 24/11/18 | 1,474 sh | $357.99 | $527,677.26 | −13.5% |
Phillip G. BillingtonSVP-Internal Audit Services | HCA HealthcareHCA | Open-market sale | 24/11/14 | 24/11/14 | 3,897 sh | $350.00 | $1,363,950 | −6.9% |
Erol R. AkdamarGroup President | HCA HealthcareHCA | Open-market sale | 24/11/14 | 24/11/14 | 2,900 sh | $353.00 | $1,023,700 | −29.8% |
Michael S. CuffeEVP and Chief Clinical Officer | HCA HealthcareHCA | Open-market sale10b5-1 plan | 24/09/12 | 24/09/12 | 8,358 sh | $385.42 | $3,221,340.36 | −22.0% |
HCA HealthcareHCA | Open-market sale | 24/07/29–24/07/31 | 24/07/31 | 4,851 sh2 trades | $362.13avg. | $1,756,695.25 | −33.9% |
